Forte Biosciences, Inc. FBRX
- FB102 — Celiac Disease Phase 2
- FB102 — Vitiligo Phase 1
- FB102 — Alopecia Areata Phase 1
CD122 (3 companies · 8 programs)
Companies with an active program directed at CD122.
Medicenna Therapeutics Corp. MDNAF
- MDNA11 — Solid Tumors Phase 1
- MDNA19 Preclinical
- MDNA11 — Melanoma Phase 1
ANAPTYSBIO, INC ANAB
- ANB033 — Celiac Disease Phase 1
- ANB033 — Eosinophilic Esophagitis Phase 1